Table 1

Age, anthropometric data and clinical characteristics of the women studied

PsA N = 45

Ps N = 52

Control N = 98

P


Age (years)

60.5 ± 8.7

61.4 ± 9.1

60.1 ± 8.4

0.95

Weight (kg)

69.4 ± 8.9

71.1 ± 14.2

67.8 ± 11.2

0.19

Height (m)

1.50 ± 0.7

1.50 ± 0.6

1.55 ± 0.6

0.97

BMI (kg/m2)

29.1 ± 3.6

26.6 ± 6.2

28.1 ± 4.54

0.19

Within ideal weight range *

N (%)

7 (15.6)

9 (17.3)

25 (25.5)

0.29

Overweight

N (%)

17 (37.8)

22 (42.3)

40 (40.8)

0.9

Obese

N (%)

21 (46.7)

21 (40.4)

33 (33.7)

0.31

Ps Duration (years)

24.8 ± 16.2

21.8 ± 17.8

-

0.39

PsA Duration (years)

11 ± 10.5

-

-

-

PASI

2.2 ± 3.3

3.2 ± 3.4

-

0.22

HAQ

0.7 ± 0.5§||

0.2 ± 0.3

0.1 ± 0.2

<0.001

DAS28

3.7 ± 1.4

-

-

-

PsARC

N° of swollen joints

3.2 ± 2.9

-

-

-

N° of painful joints

3.5 ± 3.4

-

-

-

Global evaluation of patient (VAS)

4 ± 2.8

-

-

-

Global evaluation of physician (VAS)

3.3 ± 2.4

-

-

-

Years since of menopause

12.7 ± 9.9

15.4 ± 10.9

12.1 ± 8.6

0.22


*BMI 18.50 - 24.99 kg/m2; BMI 25 - 29.99 kg/m2; BMI ≥ 30 kg/m2

DAS28, disease activity score 28; HAQ, health assessment questionnaire; PASI, psoriasis area severity index; PsA, psoriatic arthritis; Ps, psoriasis; PsARC, psoriatic arthritis response criteria; VAS, visual analogue scale.

§P < 0.001 (PsA vs. Ps)

||P < 0.001 (PsA vs. control)

Pedreira et al. Arthritis Research & Therapy 2011 13:R16   doi:10.1186/ar3240

Open Data